H. SATIŞ Et Al. , "Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register," RHEUMATOLOGY , vol.58, no.8, pp.1509-1510, 2019
SATIŞ, H. Et Al. 2019. Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register. RHEUMATOLOGY , vol.58, no.8 , 1509-1510.
SATIŞ, H., Can, G. E., Salman, R. B., AVANOĞLU GÜLER, A., KARADENİZ, H., & TUFAN, A., (2019). Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register. RHEUMATOLOGY , vol.58, no.8, 1509-1510.
SATIŞ, HASAN Et Al. "Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register," RHEUMATOLOGY , vol.58, no.8, 1509-1510, 2019
SATIŞ, HASAN Et Al. "Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register." RHEUMATOLOGY , vol.58, no.8, pp.1509-1510, 2019
SATIŞ, H. Et Al. (2019) . "Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register." RHEUMATOLOGY , vol.58, no.8, pp.1509-1510.
@article{article, author={HASAN SATIŞ Et Al. }, title={Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register}, journal={RHEUMATOLOGY}, year=2019, pages={1509-1510} }